RBC Europe’s ESSA Pharma EPIX Stock Holding History

RBC Europe’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-178	Closed	-$1.42K	–	781
2021 Q3	$1.42K	Hold	178	–	–	﹤0.01%	1159
2021 Q2	$5.08K	Hold	178	–	–	﹤0.01%	1044
2021 Q1	$5.17K	Hold	178	–	–	﹤0.01%	1000
2020 Q4	$2.12K	Hold	178	–	–	﹤0.01%	1044
2020 Q3	$1.23K	Hold	178	–	–	﹤0.01%	1008
2020 Q2	$1.1K	Hold	178	–	–	﹤0.01%	986
2020 Q1	$712	Hold	178	–	–	﹤0.01%	971
2019 Q4	$979	Hold	178	–	–	﹤0.01%	992
2019 Q3	$600	Buy	+178	New	+$439	﹤0.01%	1007

Other funds holding EPIX

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

RBC Europe's EPIX Position: Q4 2021 in Review

RBC Europe sold out of ESSA Pharma (EPIX) in Q4 2021, closing a stake of 178 shares — an estimated $1.42K sold.

RBC Europe first reported a position in EPIX in Q3 2019 and held it in 9 quarters. The position peaked at $5.17K in Q1 2021. 60 funds tracked by Wall St. Rank hold EPIX as of Q4 2021.

RBC Europe reported no remaining ESSA Pharma position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 178 ESSA Pharma shares in Q4 2021, an estimated $1.42K.
RBC Europe first reported a position in ESSA Pharma in Q3 2019 and held it in 9 quarters.
RBC Europe's ESSA Pharma position peaked at $5.17K in Q1 2021.
60 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.